Gilead Sciences GILD Valuation Implications of Expanded Kymera Therapeutics Collaboration and Kymeras FDA Fast Track Designation OPTU Optimum falls 958 as Q4 2025 earnings per share drastically underperform analyst expectations REGCP Regency delivers 153 percent Q4 2025 EPS surprise shares rise 104 percent on strong quarterly results AGMF Farmer Mac F management shares agricultural credit market outlook alongside latest quarterly earnings release Vanguard Financials Index Fund ETF VFH Q1 Big Bank Earnings Tailwinds Point to NearTerm Upside FRD Friedman Industries stock gains 414 percent following the release of its Q3 2024 earnings report